Demystifying Gluten Intolerance: All You Need to Know About Gluten Intolerance Tests

Gluten intolerance, also known as non-celiac gluten sensitivity, is a condition that affects a growing number of individuals worldwide. It is characterized by adverse reactions to gluten-containing foods, leading to symptoms such as gastrointestinal discomfort, bloating, fatigue, and brain fog. 

Accurate diagnosis is crucial for managing gluten intolerance and maintaining a healthy lifestyle. In this article, we will explore the different testing methods available for diagnosing gluten intolerance, providing you with a comprehensive understanding of each test's purpose, advantages, and limitations.

While the exact mechanisms of gluten intolerance are not fully understood, it is believed to involve a non-immunological reaction to gluten. When people with gluten intolerance consume gluten, they experience a range of symptoms that can vary in intensity and duration. These symptoms primarily affect the gastrointestinal system but can also impact other areas of the body, such as the central nervous system.

Gluten Intolerance Tests

To accurately diagnose gluten intolerance, various tests are available, each serving a different purpose and providing unique insights into an individual's condition. These tests help determine whether gluten is the underlying cause of an individual's symptoms and guide appropriate management strategies. It is important to understand the different testing methods to choose the most suitable approach in collaboration with healthcare professionals.

Blood Tests for Gluten Intolerance:

 

Serology tests are commonly used to screen for gluten intolerance. They detect specific antibodies in the blood that indicate an immune response triggered by gluten. The three main types of serology tests for gluten intolerance are:

Anti-tissue transglutaminase (tTG) antibodies:

Anti-tissue transglutaminase antibodies are the most widely used  blood test for diagnosing gluten-related disorders. Tissue transglutaminase is an enzyme found in the lining of the small intestine, and in those with gluten intolerance or celiac disease, gluten triggers an immune response that leads to the production of these antibodies. Elevated levels of anti-tTG antibodies suggest an immune reaction to gluten and are indicative of gluten intolerance.

Anti-endomysial antibodies (EMA):

Anti-endomysial antibodies are antibodies that target the endomysium, a connective tissue surrounding the muscle fibers. EMA antibodies are often present in celiac disease, but they can also be detected in some cases of gluten intolerance. The presence of EMA antibodies in the blood suggests an immune response to gluten and indicates the possibility of gluten intolerance.

Deamidated gliadin peptide (DGP) antibodies:

Deamidated gliadin peptide antibodies recognize a modified form of gliadin, a protein found in gluten. These antibodies are sensitive indicators of immune reactions to gluten and are commonly used in the diagnosis of gluten intolerance. Elevated levels of DGP antibodies may suggest the presence of gluten intolerance.

Accuracy and limitations of blood tests

Blood tests for gluten intolerance have a reasonable level of accuracy but are not always conclusive. False negatives can occur, especially if gluten has been eliminated from the diet prior to testing, as the production of antibodies may decrease. Additionally, false positives can occur in those who may have elevated antibody levels for reasons other than gluten intolerance. It is important to consider these limitations and interpret blood test results in conjunction with other clinical information and test results. If there is a strong suspicion of gluten intolerance despite negative blood test results, further testing or alternative diagnostic methods, such as an elimination diet or biopsy, may be necessary to confirm the diagnosis.

Genetic Tests for Gluten Intolerance:

 

Human leukocyte antigen (HLA) genes are a group of genes that encode proteins involved in the regulation of the immune system. Certain HLA genes, such as HLA-DQ2 and HLA-DQ8, have a strong association with gluten-related disorders, including celiac disease and gluten intolerance. These genes are involved in presenting gluten peptides to immune cells, potentially triggering an immune response. The presence of specific HLA gene variants can indicate an increased genetic susceptibility to gluten-related disorders.

Genetic tests can identify the presence of specific HLA gene variants associated with gluten-related disorders. If an individual carries these genetic markers, it suggests an increased genetic susceptibility to developing gluten intolerance. However, it is important to note that the presence of these genetic markers does not necessarily mean an individual will develop gluten intolerance. Genetic tests alone cannot provide a definitive diagnosis for gluten intolerance but can help identify people who may be at a higher risk and guide further diagnostic investigations.

Genetic testing is most useful when combined with other diagnostic methods, such as blood tests, biopsy, or an elimination diet, to provide a comprehensive evaluation of an individual's risk and potential diagnosis of gluten intolerance.

Biopsy and Endoscopy

A biopsy is a medical procedure in which a small tissue sample is taken from the lining of the small intestine for microscopic examination. Endoscopy is the procedure used to obtain the biopsy sample. During an endoscopy, a thin, flexible tube called an endoscope is inserted through the mouth and guided into the small intestine. The endoscope has a camera attached to it, which allows the doctor to visualize the intestinal lining and collect biopsy samples using small instruments.

The purpose of a biopsy in the context of gluten intolerance is to assess the presence of characteristic changes in the intestinal tissue. In gluten intolerance, these changes may include increased intraepithelial lymphocytes, damage to the epithelial lining, or other signs of inflammation. Biopsies can help differentiate between gluten intolerance and other conditions, such as celiac disease or inflammatory bowel disease, and confirm the diagnosis.

Importance of biopsy for accurate diagnosis

 

Biopsies are considered the gold standard for diagnosing celiac disease and are sometimes performed in cases of suspected gluten intolerance. They provide direct evidence of the intestinal changes associated with gluten-related disorders. Biopsies can help confirm or rule out gluten intolerance when other diagnostic tests, such as blood tests, are inconclusive or when there is a need for definitive confirmation.

Potential complications and risks associated with the procedure

Although endoscopy with biopsy is generally considered safe, like any medical procedure, there are potential risks and complications. These can include bleeding, infection, perforation of the intestine, adverse reactions to anesthesia or sedation, and rare complications related to endoscope insertion. However, the risk of complications is relatively low when the procedure is performed by experienced healthcare professionals in a controlled medical environment. It is important to discuss any concerns or potential risks with the healthcare provider prior to undergoing the procedure.

Elimination Diet and Food Challenges

An elimination diet is a dietary approach in which all sources of gluten are completely removed from the individual's diet for a designated period, usually several weeks to a couple of months. During this time, you should carefully avoid consuming foods that contain wheat, barley, rye, and their derivatives. The purpose of the elimination diet is to observe and assess the improvement or resolution of symptoms in response to the elimination of gluten. If symptoms significantly improve during the elimination phase, it suggests the possibility of gluten intolerance.

After the elimination phase, a supervised food challenge may be conducted to confirm the diagnosis of gluten intolerance. In a food challenge, gluten-containing foods are gradually reintroduced into the individual's diet while closely monitoring for the return of symptoms. This controlled reintroduction helps identify whether gluten is indeed the cause of the adverse reactions observed during the elimination phase.

Elimination diets and food challenges can be challenging to implement and require strict adherence to a gluten-free diet. It is important to work with a healthcare professional or a registered dietitian experienced in gluten-related disorders to ensure nutritional adequacy and to address any concerns or difficulties during the process. Additionally, the success of an elimination diet depends on accurately identifying and avoiding all sources of gluten, which may require careful reading of food labels and education on hidden sources of gluten in processed foods. The process of reintroducing gluten during food challenges should be conducted under medical supervision to ensure safety and accurate

Interpreting Test Results

 

Interpreting test results for gluten intolerance requires understanding the significance of both positive and negative results. 

Positive results

A positive result in a gluten intolerance test, such as elevated levels of specific antibodies or characteristic biopsy findings, suggests the presence of an immune response to gluten. It indicates that gluten may be the underlying cause of the individual's symptoms and supports a diagnosis of gluten intolerance. Positive results provide valuable information for healthcare professionals in guiding treatment and management strategies, including adherence to a  gluten-free diet.

Negative results

A negative result, on the other hand, does not definitively rule out gluten intolerance. It means that the specific markers or antibodies tested for were not detected in the individual's blood or that the biopsy did not show characteristic changes associated with gluten intolerance. However, false negatives can occur for various reasons. For example, if an individual has already eliminated gluten from their diet before testing, it can reduce the production of specific antibodies and lead to a false negative result. Therefore, a negative result does not necessarily exclude the possibility of gluten intolerance, especially if symptoms persist or there is a strong clinical suspicion. Further testing or alternative diagnostic approaches, such as an elimination diet or consultation with a specialist, may be warranted in such cases.

Factors that can affect test accuracy and reliability

Several factors can impact the accuracy and reliability of gluten intolerance tests. It is important to consider these factors when interpreting test results:

Gluten intake

For blood tests, consuming gluten-containing foods before the test is crucial to ensure accurate results. If an individual has already eliminated gluten from their diet, the production of specific antibodies may decrease, leading to false negative results. It is essential to inform the patient about the importance of gluten consumption prior to testing to improve test accuracy.

Individual variation

Each person's immune system and response to gluten can differ, leading to variations in test results. Some may have heightened immune responses and show positive results even with mild exposure to gluten, while others may have less pronounced immune responses and show negative results despite ongoing symptoms. Understanding these individual variations is important for accurate interpretation.

Test sensitivity and specificity

Different tests have varying levels of sensitivity and specificity. Sensitivity refers to the ability of a test to correctly identify people with the condition (true positive rate), while specificity refers to the ability to correctly identify those without the condition (true negative rate). It is important to consider the sensitivity and specificity of the specific test used and interpret the results accordingly.

Concurrent conditions or medications

Certain medical conditions or medications can influence test results. For example, individuals with autoimmune disorders or immunosuppressive medications may have altered immune responses, potentially affecting the accuracy of serology tests. It is crucial to consider these factors when interpreting results and consult with a healthcare professional for a comprehensive evaluation.

It is important to remember that self-diagnosis based solely on test results obtained online or without professional guidance can lead to misunderstandings and inappropriate management approaches. A healthcare professional can provide the necessary guidance, support, and expertise to ensure accurate interpretation of test results and appropriate management strategies for gluten intolerance.

The Takeaway

Accurate diagnosis is crucial in managing gluten intolerance effectively. Blood tests, genetic tests, biopsies, and elimination diets all play a role in identifying gluten intolerance. Each test provides unique insights into an individual's condition and contributes to a comprehensive diagnostic approach. 

It is important to consult with a healthcare professional who can guide you through the testing process, help interpret the results accurately, and provide appropriate advice and support. By properly understanding gluten intolerance tests, you can gain a better understanding of their condition and take appropriate steps towards a gluten-free lifestyle for improved health and well-being.

Watch AFIL test kits testimonial videos click here

References

1. Volta, Umberto, et al. "Serological tests in gluten sensitivity (nonceliac gluten intolerance)." Journal of clinical gastroenterology 46.8 (2012): 680-685.
2. Denery-Papini, S., Y. Nicolas, and Y. Popineau. "Efficiency and limitations of immunochemical assays for the testing of gluten-free foods." Journal of Cereal Science 30.2 (1999): 121-131.
3. Unsworth, D. J., et al. "New immunofluorescent blood test for gluten sensitivity." Archives of Disease in Childhood 56.11 (1981): 864-868.
4. Comino, Isabel, et al. "The gluten-free diet: testing alternative cereals tolerated by celiac patients." Nutrients 5.10 (2013): 4250-4268.
5. Bizzaro, N., et al. "Cutting-edge issues in celiac disease and in gluten intolerance." Clinical reviews in allergy & immunology 42 (2012): 279-287.